Mark Hamilton Shares New Findings on CAR T-Cell-Associated Enterocolitis
Mark Hamilton/LinkedIn

Mark Hamilton Shares New Findings on CAR T-Cell-Associated Enterocolitis

Mark Hamilton, Assistant Professor at MD Anderson Cancer Center, shared on LinkedIn:

“Happy to see our work in immune effector cell associated enterocolitis out in Nature Medicine.

IEC-EC is a rare but devastating pathology where in many cases the CAR T-cells we use to treat our patients turn against the body and invade into the small bowel. We find that these cells are highly clonal and invade principally into the duodenum. Patients who develop this disorder have unusually high levels of circulating CAR T-cells after infusion defining the at-risk population. Though the CAR T-cell infiltrate is cytotoxic and clonal, we don’t find clear evidence of recurrent DNA-mutations or insertional mutagenesis.

The incredible effort that went into this study from our team at MD Anderson and nationally with the US Multiple Myeloma Immunotherapy Consortium was principally performed to meet a clinical need due to the high levels of morbidity and mortality that we saw in our patients. Through teamwork we were able to develop diagnostic and clinical algorithms that have improved outcomes. I deeply appreciate not only our students leading the effort, but our close collaborators at MD Anderson in GI and pathology.

Finally I am proud of the collaborative effort that went into this paper and allowed extensive data sharing and cross validation of major results with centers across the US, including co-submission of the consortia work led by my collaborator and friend Lekha Mikkilineni. Working together to understand and improve our patients’ outcomes is how we all shine brightest.”

Title: Multicenter characterization of enterocolitis associated with BCMA-directed CAR T cell therapy

Authors: Lekha Mikkilineni, Mark P. Hamilton, Alexandria Jensen, Kenneth JC Lim, Gliceida M. Galarza-Fortuna, Anupama D. Kumar, Christopher J. Ferreri, Andrew J. Portuguese, Hitomi Hosoya, Sharlene Dong, Nadine H. Abdallah, Jinming Song, Rebecca Gonzalez, Anna Shestakova, Navreet Chowla, Zongming Eric Chen, Amandeep Godara, Ghulam Rehman Mohyuddin,

Max N. Brondfield, Dana Balitzer, Christopher J. Bowman, Omar Castaneda Puglianini, Michael G. Kattah, Frederick L. Locke, Louis S. Williams, Alaa Ali, Binod Dhakal, Rahul Banerjee, Metin Ozdemirli, David B. Miklos, Krina K. Patel, Douglas W. Sborov, Ajai Chari, Thomas Martin, Surbhi Sidana, Yi Lin, Francisco Vega, Sebastian Fernandez-Pol, Doris K. Hansen, David Y. Oh, Jeffrey L. Wolf

Tania P. Sainz, Graduate Student Research Assistant at MD Anderson Cancer Center added:

“I am pleased to share our recent publication in Nature Medicine on immune effector cell associated enterocolitis, a rare but serious complication of CAR T-cell therapy.

It was a privilege to serve as co-first author alongside Aniruddha Mundhada and Sharlene Dong. I am grateful to Mark Hamilton, Francisco Vega, and Krina Patel for their mentorship, and to our colleagues at UT MD Anderson and across the US Multiple Myeloma Immunotherapy Consortium for their collaboration.”

Title: Expansion and cytotoxicity of mucosal CAR+ T cells in enterocolitis associated with BCMA CAR-T cell therapy

Authors: Tania P. Sainz, Sharlene Dong, Aniruddha Mundhada, Wei Wang, Hector Garcia Pleitez, Carla Villela, Jared Henderson, Amy A. Ayers, Karmila Murphy, Francisco Cortina, Bita Sahaf, Snehit Prabhu, Partow Kebriaei, Wei-Lien Wang, Christopher D. Pacheco, Xuehong Gui, Christopher R. Flowers, Sattva S. Neelapu, Paolo Strati, Mahmoud R. Gaballa, Oren Pasvolsky, Robert Orlowski, Keyur Patel, Surbhi Sidana, Crystal Mackall, David B. Miklos, Yinghong Wang, David M. Richards, Sairah Ahmed, Michael R. Green, Lekha Mikkilineni, Sa A. Wang, Ziyi Li, Swami P. Iyer, Krina K. Patel, Francisco Vega, Mark P. Hamilton

Read the Full Article

You may also be interested in:

Nabil Chehab: AstraZeneca Explores the Future of CAR-T Cell Therapy Across Cancer and Autoimmune Diseases